Skip to main content

Brown Michael S's Form 4 filing

Regeneron Pharmaceuticals, Inc. (REGN) · filed Nov 10, 2022

Accession no.
0001883850-22-000094
Filed
Nov 10, 2022
Trade date
Nov 8, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 16 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.39M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Brown Michael SCIK 0001174475Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 8, 2022Common StockMOption exerciseAcquired+2,431$374.12+$909,485.723,513Direct
Nov 8, 2022Common StockSSaleDisposed−1,764$748.48F2−$1,320,318.721,749Direct
Nov 8, 2022Common StockMOption exerciseAcquired+1,564$482.68+$754,911.523,313Direct
Nov 8, 2022Common StockSSaleDisposed−126$751.23F3−$94,654.983,187Direct
Nov 8, 2022Common StockSSaleDisposed−203$752.14F4−$152,684.422,984Direct
Nov 8, 2022Common StockSSaleDisposed−300$753.66F5−$226,0982,684Direct
Nov 8, 2022Common StockSSaleDisposed−200$754.70F6−$150,9402,484Direct
Nov 8, 2022Common StockSSaleDisposed−200$760.70F7−$152,1402,284Direct
Nov 8, 2022Common StockSSaleDisposed−100$761.53−$76,1532,184Direct
Nov 8, 2022Common StockSSaleDisposed−200$763.19F8−$152,6381,984Direct
Nov 8, 2022Common StockSSaleDisposed−200$764.23F9−$152,8461,784Direct
Nov 8, 2022Common StockSSaleDisposed−100$765.19−$76,5191,684Direct
Nov 8, 2022Common StockSSaleDisposed−201$766.74F10−$154,114.741,483Direct
Nov 8, 2022Common StockSSaleDisposed−201$767.25F11−$154,217.251,282Direct
Nov 8, 2022Common StockSSaleDisposed−200$768.11F12−$153,6221,082Direct
Nov 8, 2022Common StockSSaleDisposed−500$748.49−$374,2456,662Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 8, 2022Common StockMOption exerciseDisposed−2,431$0.00$00Direct
Nov 8, 2022Common StockMOption exerciseDisposed−1,564$0.00$02,049Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Represents volume-weighted average price of sales of 1,764 shares of Company stock on November 8, 2022 at prices ranging from $748.24 to $748.58. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2022 at each separate price.

Referenced by the price of 1 transaction in Table I.

F3

Represents volume-weighted average price of sales of 126 shares of Company stock on November 8, 2022 at prices ranging from $751.10 to $751.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2022 at each separate price.

Referenced by the price of 1 transaction in Table I.

F4

Represents volume-weighted average price of sales of 203 shares of Company stock on November 8, 2022 at prices ranging from $752.02 to $752.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2022 at each separate price.

Referenced by the price of 1 transaction in Table I.

F5

Represents volume-weighted average price of sales of 300 shares of Company stock on November 8, 2022 at prices ranging from $753.15 to $753.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2022 at each separate price.

Referenced by the price of 1 transaction in Table I.

F6

Represents volume-weighted average price of sales of 200 shares of Company stock on November 8, 2022 at prices ranging from $754.68 to $754.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2022 at each separate price.

Referenced by the price of 1 transaction in Table I.

F7

Represents volume-weighted average price of sales of 200 shares of Company stock on November 8, 2022 at prices ranging from $760.50 to $760.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2022 at each separate price.

Referenced by the price of 1 transaction in Table I.

F8

Represents volume-weighted average price of sales of 200 shares of Company stock on November 8, 2022 at prices ranging from $763.18 to $763.19. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2022 at each separate price.

Referenced by the price of 1 transaction in Table I.

F9

Represents volume-weighted average price of sales of 200 shares of Company stock on November 8, 2022 at prices ranging from $764.10 to $764.35. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2022 at each separate price.

Referenced by the price of 1 transaction in Table I.

F10

Represents volume-weighted average price of sales of 201 shares of Company stock on November 8, 2022 at prices ranging from $766.59 to $766.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2022 at each separate price.

Referenced by the price of 1 transaction in Table I.

F11

Represents volume-weighted average price of sales of 201 shares of Company stock on November 8, 2022 at prices ranging from $767.09 to $767.36. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2022 at each separate price.

Referenced by the price of 1 transaction in Table I.

F12

Represents volume-weighted average price of sales of 200 shares of Company stock on November 8, 2022 at prices ranging from $768.08 to $768.14. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2022 at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)